Feature | Data |
---|---|
Age | 26–89 years (median 57) |
Gender | 55 F/6 M |
Tumor sizea | 0.5–13 cm (4.5 cm); n = 49 |
Synchronous PTC | 7/44 (16%) |
Background of LT | 42/44 (95%) |
Extrathyroidal extension | 28/52 (54%) |
Lymph node metastases | 20/50 (40%) |
Distant metastases | 8/54 (15%) |
IHC: | |
Cytokeratin | 32/32 (100%) |
Carcinoembryonic antigen | 16/21 (76%) |
Thyroglobulin | 3/56 (5%) |
Mucin | 7/7 (100%) |
p63 | 24/24 (100%) |
Thyroid transcription factor-1 | 9/19 (47%) |
Chromogranin | 0/12 (0%) |
Calcitonin | 0/41 (0%) |
Outcome data | |
Alive without disease | 25/40 (63%) |
Alive with disease | 6/40 (15%) |
Deceased | 9/40 (23%) |